Vaxxas Announces and Publishes Successful Phase I Clinical Trial for Measles and Rubella Vaccine Delivered Using its Proprietary High-Density Microarray Skin Patch; Plan for Phase I/II Trial in The Gambia, Africa

vaccine - Trending on BuzzSumo 2023-11-26

Summary:

Vaxxas Announces and Publishes Successful Phase I Clinical Trial for Measles and Rubella Vaccine Delivered Using its Proprietary High-Density Microarray Skin Patch; Plan for Phase I/II Trial in The Gambia, Africa drj.com

Link:

https://drj.com/industry_news/vaxxas-announces-and-publishes-successful-phase-i-clinical-trial-for-measles-and-rubella-vaccine-delivered-using-its-proprietary-high-density-microarray-skin-patch-plan-for-phase-i-ii-trial-in-the-ga/

From feeds:

Tags:

all_vaccine

Authors:

Rachel Mezinis

Date tagged:

11/26/2023, 22:54

Date published:

11/26/2023, 18:34